InMode Ltd vs Global X SuperDividend ETF — how do they compare? InMode Ltd trades at $14.07 (market cap $806.05M), while Global X SuperDividend ETF trades at $23.75 (market cap $1.17B). The key difference: Global X SuperDividend ETF is the larger of the two by market cap, and InMode Ltd is more actively traded (511,446 versus 432,039). Which is the better fit depends on your goals — on Pluang, investors hold InMode Ltd for 29 Days and Global X SuperDividend ETF for 47 Days on average.
| INMD | SDIV | |
|---|---|---|
Market Cap | $806.05M | $1.17B |
Volume | 511,446 | 432,039 |
Sector | Health | Broad Market / Factor |
52-Week High | $16.62 | $26.34 |
52-Week Low | $12.76 | $22.90 |
Typical Hold Time | 29 Days | 47 Days |
Enterprise Value | $309.39M | — |
Signals from Pluang's Aura AI — not financial advice
INMD trades at $14.01, showing minimal daily movement with a 0.14% gain. The stock faces bearish technical signals despite attractive valuation metrics including a P/E of 11.58 and EV/EBITDA of 4.43. Recent earnings show mixed results with Q2 2026 beating expectations but Q1 2026 missing, while the company faces shareholder activism from Steel Partners' $16.75 per share acquisition offer. Revenue guidance for 2026 remains stable at $365M-$375M.
The investment case balances strong profitability margins against technical weakness and activist pressure. With 45% analyst buy ratings and no sell recommendations, fundamental value appears intact, but near-term price action suggests caution. Key catalysts include Q3 2026 earnings and resolution of the acquisition proposal, while risks include execution challenges and macroeconomic headwinds affecting aesthetic medicine demand.
SDIV trades at $23.58, down 0.55% with a bearish technical signal from moving averages. The ETF maintains an 8%+ dividend yield but faces scrutiny over principal erosion, having lost 66% since inception. Recent institutional buying by Ameritas Advisory contrasts with negative media coverage questioning sustainability of high yields amid capital depreciation.
Outlook remains challenged by structural underperformance versus benchmarks. The high yield attracts income seekers but masks negative growth and volatility risks. Investment case hinges on yield sustainability versus capital preservation, with analyst sentiment cautious given persistent track record of value destruction.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →SDIV is an ETF that invests in 100 of the highest dividend-yielding equity securities in the world. The fund seeks to provide a high level of income to investors by selecting companies from both developed and emerging markets that have historically provided high dividend yields. By diversifying globally, SDIV aims to mitigate risks associated with focusing on a single country, while offering monthly distributions to its shareholders.
Read more on SDIV →